In summary, Raife et al. present quite provocative data. The potential use of a hirudin analogue to reverse the pathophysiologic cascade leading to HUS raises interesting questions. However, the best way to prevent HUS remains the prevention of primary human infection with E. coli O157:H7 and other STEC.

Original languageEnglish
Pages (from-to)227-228
Number of pages2
JournalThrombosis and haemostasis
Issue number2
StatePublished - Aug 1 2004


Dive into the research topics of 'Shiga toxin-induced thrombotic microangiopathy: A thrombin-dependent process?'. Together they form a unique fingerprint.

Cite this